Source: International Congress 2018 – Novel drug targets for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Allinne (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), A. Agrawal (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), J. Kim (Tarrytown, United States of America), V. Kamat (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America). IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.. 1944

Member's Comments

No comment yet.

Related content which might interest you: IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 The effects of capsaicin on airway inflammation in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Resolution of inflammation in airway diseases Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017